Drugs / AZA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02319369 | Nov 2014 → Aug 2020 | acute myeloid leukemia, myelodysplastic syndrome | Daiichi Sankyo | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02319369 ↗ |
| Route | Subcutaneous | “subcutaneously” NCT02319369 ↗ |